29.52
price down icon0.77%   -0.23
pre-market  プレマーケット:  29.00   -0.52   -1.76%
loading
前日終値:
$29.75
開ける:
$29.97
24時間の取引高:
279.98K
Relative Volume:
0.62
時価総額:
$1.29B
収益:
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+3.58%
1か月 パフォーマンス:
+28.68%
6か月 パフォーマンス:
+223.33%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
Value
$29.00
$31.93
1週間の範囲:
Value
$27.54
$31.93
52週間の値動き範囲:
Value
$6.71
$31.93

Maze Therapeutics Inc Stock (MAZE) Company Profile

Name
名前
Maze Therapeutics Inc
Name
セクター
Healthcare (1139)
Name
電話
(650) 850-5070
Name
住所
171 OYSTER POINT BOULEVARD, SUITE 300, SOUTH SAN FRANCISCO
Name
職員
125
Name
Twitter
Name
次回の収益日
Name
最新のSEC提出書
Name
MAZE's Discussions on Twitter

MAZE を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
MAZE
Maze Therapeutics Inc
29.52 1.43B 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
426.27 107.45B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
474.00 64.39B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
579.34 61.13B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
834.75 52.30B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
165.31 35.49B 398.11M -1.03B -868.57M -5.7032

Maze Therapeutics Inc Stock (MAZE) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-09-02 開始されました BTIG Research Buy
2025-07-23 開始されました H.C. Wainwright Buy
2025-07-08 開始されました Wedbush Outperform

Maze Therapeutics Inc (MAZE) 最新ニュース

pulisher
Oct 21, 2025

Pattern recognition hints at Maze Therapeutics Inc. upsideWeekly Trade Review & Long-Term Safe Investment Plans - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Does Maze Therapeutics Inc. qualify in momentum factor screeningNew Guidance & Verified Momentum Stock Watchlist - newser.com

Oct 21, 2025
pulisher
Oct 20, 2025

Developing predictive dashboards with Maze Therapeutics Inc. dataJuly 2025 Opening Moves & Advanced Technical Signal Analysis - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Will Maze Therapeutics Inc. outperform the marketPortfolio Update Report & Verified Momentum Watchlists - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

What is the fair value of Maze Therapeutics Inc. stock nowJuly 2025 Levels & Precise Buy Zone Identification - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Can Maze Therapeutics Inc. stock beat market expectations this quarterPortfolio Profit Report & Real-Time Buy Zone Alerts - newser.com

Oct 20, 2025
pulisher
Oct 19, 2025

Why Maze Therapeutics Inc. is moving todayWeekly Profit Recap & Verified High Yield Trade Plans - newser.com

Oct 19, 2025
pulisher
Oct 18, 2025

Maze Therapeutics Inc. recovery potential after sell offVolume Spike & Daily Market Momentum Tracking - newser.com

Oct 18, 2025
pulisher
Oct 18, 2025

Can Maze Therapeutics Inc. stock deliver sustainable ROEJuly 2025 Action & Real-Time Stock Price Movement Reports - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 18, 2025

Is Maze Therapeutics Inc. stock a top momentum playTrade Exit Summary & Community Consensus Stock Picks - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 18, 2025

Will Maze Therapeutics Inc. stock rally after Fed decisionsQuarterly Market Review & Technical Entry and Exit Alerts - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 18, 2025

What drives Maze Therapeutics Inc stock priceDividend Growth Stocks & Analyze Your Portfolio Risk in Seconds - earlytimes.in

Oct 18, 2025
pulisher
Oct 18, 2025

Portfolio Update: Will Maze Therapeutics Inc. stock benefit from AI adoptionMarket Volume Report & Verified Momentum Watchlists - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 18, 2025

Will Maze Therapeutics Inc. stock benefit from AI adoptionPortfolio Return Summary & Verified Chart Pattern Signals - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 11, 2025

ETFs Investing in Maze Therapeutics, Inc. Stocks - TradingView

Oct 11, 2025
pulisher
Oct 10, 2025

Weiss Ratings Reaffirms "Sell (D)" Rating for Maze Therapeutics (NASDAQ:MAZE) - MarketBeat

Oct 10, 2025
pulisher
Oct 10, 2025

Can a trend reversal in Maze Therapeutics Inc. lead to recovery2025 Fundamental Recap & Capital Protection Trade Alerts - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

How to use a screener to detect Maze Therapeutics Inc. breakoutsWall Street Watch & Free Daily Entry Point Trade Alerts - newser.com

Oct 09, 2025
pulisher
Oct 06, 2025

Pompe Disease Market Research 2025: Treatment, Route of Administration, and Region Analysis and Forecast to 2035 Featuring Amicus Therapeutics, Astellas, BioMarin, Maze Therapeutics, Oxyrane ParasailResearchAndMarkets.com - The AI Journal

Oct 06, 2025
pulisher
Oct 06, 2025

Maze Therapeutics (NASDAQ:MAZE) Reaches New 1-Year HighWhat's Next? - MarketBeat

Oct 06, 2025
pulisher
Oct 06, 2025

Maze Therapeutics Appoints Herve Hoppenot as Board Chairman - MarketScreener

Oct 06, 2025
pulisher
Oct 06, 2025

What technical models suggest about Maze Therapeutics Inc.’s comeback2025 Major Catalysts & Long Hold Capital Preservation Plans - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Maze Therapeutics appoints Hervé Hoppenot as chairman of the board - Investing.com

Oct 06, 2025
pulisher
Oct 06, 2025

Maze Therapeutics Appoints Hervé Hoppenot as Chairman - TipRanks

Oct 06, 2025
pulisher
Oct 06, 2025

Maze Therapeutics appoints Hervé Hoppenot as board chairman - Investing.com India

Oct 06, 2025
pulisher
Oct 06, 2025

Maze Therapeutics appoints Hervé Hoppenot as board chairman By Investing.com - Investing.com Australia

Oct 06, 2025
pulisher
Oct 06, 2025

Maze Therapeutics Appoints Industry Veteran Hervé Hoppenot as Chairman of the Board of Directors - GlobeNewswire

Oct 06, 2025
pulisher
Oct 06, 2025

Detecting price anomalies in Maze Therapeutics Inc. with AI2025 Sector Review & Growth Focused Stock Pick Reports - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Predicting Maze Therapeutics Inc. trend using moving averages2025 Top Decliners & Verified Swing Trading Watchlist - newser.com

Oct 05, 2025
pulisher
Oct 04, 2025

Maze Therapeutics (MAZE): Assessing Current Valuation Following a 78% Monthly Share Price Surge - Sahm

Oct 04, 2025
pulisher
Oct 04, 2025

Maze Therapeutics (MAZE): Assessing Valuation After 78% 30-Day Share Price Surge - Yahoo Finance

Oct 04, 2025
pulisher
Oct 03, 2025

Maze Therapeutics, Inc. (MAZE) Stock Analysis: Insights into a Biotech with 42.77% Potential Upside - DirectorsTalk Interviews

Oct 03, 2025

Maze Therapeutics Inc (MAZE) 財務データ

Maze Therapeutics Inc (MAZE) の財務データはありません。詳細については、他の銘柄を確認してください。

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$37.48
price up icon 2.32%
$87.30
price up icon 1.31%
$30.13
price down icon 1.34%
$106.89
price down icon 0.98%
biotechnology ONC
$315.74
price down icon 0.90%
$165.31
price down icon 1.55%
大文字化:     |  ボリューム (24 時間):